Skip to main content
. Author manuscript; available in PMC: 2013 Nov 25.
Published in final edited form as: Mol Cell Endocrinol. 2012 Aug 30;364(1-2):83–88. doi: 10.1016/j.mce.2012.08.012

Figure 4.

Figure 4

Relative telomerase activity (fold induction compared to basal conditions) for PHA-treated PBMCs (left panel) and for anti-CD3/CD28-treated PBMCs (right panel). Data for women (n = 7) are shown in open bars; data for men (n = 9) are shown in filled bars.